Friday, October 16, 2020 9:15:56 PM
Thanks, others will want see that for sure. I saw his credentials back in March, which is why I bought at .02/share
I should have bought the dips too. Today I did what all the others did the last 4 rallies, I sold and took profits.
When it looks undervalued again I will buy dips, and will continue to do my own value analysis as news continues to drop.
He obviously has lots of potential to make some huge deals, and drop news bombs like this one. Impressive rally today. One thing is for sure, they can drop massive legitimate news bombs and he make some great well informed drug deals.
"Paul M Michaels - Chief Executive Officer - Connectyx Technologies
For the past two decades, established lasting relationships with key business leaders and stakeholders in Japan and the U.S., particularly in the Life Sciences field Expertise in financing, risk management, global business development, mergers and acquisitions and cross-border pharmaceutical licensing. Completed transactions that influenced companies such as Celgene Corporation, Sumitomo Pharmaceuticals, Nobelpharma Co., Ltd, Teva Pharmaceuticals, ICOS, Neurocrine, Cell Therapeutics and… "
I should have bought the dips too. Today I did what all the others did the last 4 rallies, I sold and took profits.
When it looks undervalued again I will buy dips, and will continue to do my own value analysis as news continues to drop.
He obviously has lots of potential to make some huge deals, and drop news bombs like this one. Impressive rally today. One thing is for sure, they can drop massive legitimate news bombs and he make some great well informed drug deals.
"Paul M Michaels - Chief Executive Officer - Connectyx Technologies
For the past two decades, established lasting relationships with key business leaders and stakeholders in Japan and the U.S., particularly in the Life Sciences field Expertise in financing, risk management, global business development, mergers and acquisitions and cross-border pharmaceutical licensing. Completed transactions that influenced companies such as Celgene Corporation, Sumitomo Pharmaceuticals, Nobelpharma Co., Ltd, Teva Pharmaceuticals, ICOS, Neurocrine, Cell Therapeutics and… "
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
Recent CUBT News
- Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply of Metformin Topical Ophthalmic Therapy • GlobeNewswire Inc. • 04/15/2026 12:08:00 PM
- Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting • GlobeNewswire Inc. • 03/23/2026 11:05:00 PM
- Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting • GlobeNewswire Inc. • 03/23/2026 11:00:00 AM
- Curative Biotechnology Announces Canadian Patent Allowance • GlobeNewswire Inc. • 01/23/2026 01:45:00 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 12/22/2025 06:40:01 PM
- Curative Biotechnology, Inc. Announces Letter to Shareholders • GlobeNewswire Inc. • 11/18/2025 01:15:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/01/2025 08:07:47 PM
- Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 05/09/2025 07:00:02 PM
